Catalyst Wire Dossier Catalyst Wire Dossier

amatuximab

amatuximab · Morphotek
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for amatuximab, covering 2012-03-27 to 2022-09-22. Get the full timeline:

Most recent: Clinical Trial Update: An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural Mesothelioma [Phase 2]

See pricing